BusinessUpdated 1 hr ago
Alembic Pharma Q2 net surges 81% to ₹335 crore

“U.S. business was driven by strong volume growth and new launches. In U.S. Branded, we are encouraged by the traction building across our existing portfolio,” said
Continue reading on The Hindu
Read full story Hello Headlines links you to the original publisher for the full story.




